
Alzheimer’s blood marker could predict cognitive decline risks, says Mayo Clinic
A Mayo Clinic study finds a p-tau217 blood test may predict cognitive decline risk within five to 10 years, offering a less invasive option than PET scans.
This story was published by Fox News. Read the full article on their site.
Read the full story at foxnews.com(opens in a new tab)







